| |
 |
Editorial [Hot Topic: Emerging Therapeutic Targets and Agents for Glioblastoma Therapy – Part I (Guest Editor: Hui-Wen Lo)]
 |
| |
|
pp.437-437 (1) Author: Hui-Wen Lo |
| |
|
|
| |
|
Therapeutic Exploitation of Apoptosis and Autophagy for Glioblastoma
|
| |
|
pp.438-449 (12) Authors: Donat Kogel, Simone Fulda, Michel Mittelbronn |
| |
|
|
| |
|
Exploiting Cyclooxygenase-(in)Dependent Properties of COX-2 Inhibitors for Malignant Glioma Therapy
|
| |
|
pp.450-461 (12) Author: Axel H. Schonthal |
| |
|
|
| |
|
Immunotherapy of Malignant Gliomas Using Autologous and Allogeneic Tissue Cells
|
| |
|
pp.462-470 (9) Authors: F. M. Hofman, A. Stathopoulos, C. A. Kruse, T. C. Chen, V. E.J.C. Schijns |
| |
|
|
| |
|
Mouse Induced Glioma-Initiating Cell Models and Therapeutic Targets
|
| |
|
pp.471-480 (10) Author: Toru Kondo |
| |
|
|
| |
|
Obesity Modulation - The Role in Carcinogenesis
|
| |
|
pp.481-490 (10) Authors: Ioannis Legakis, Kostantinos Syrigos |
| |
|
|
| |
|
Epidermal Growth Factor Receptor as a Target for Anti-Cancer Agent Design
|
| |
|
pp.491-503 (13) Authors: Jiangying Cao, Hao Fang, Binghe Wang, Chunhua Ma, Wenfang Xu |
| |
|
|
| |
|
Combination Therapy with Arsenic Trioxide for Hematological Malignancies
|
| |
|
pp.504-510 (7) Author: Shinichiro Takahashi |
| |
|
|
